(GLAD) Gladstone Capital - Overview
Stock: Debt, Equity, Mezzanine
| Risk 5d forecast | |
|---|---|
| Volatility | 19.7% |
| Relative Tail Risk | 4.04% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.23 |
| Alpha | -38.65 |
| Character TTM | |
|---|---|
| Beta | 0.744 |
| Beta Downside | 0.891 |
| Drawdowns 3y | |
|---|---|
| Max DD | 33.56% |
| CAGR/Max DD | 0.17 |
EPS (Earnings per Share)
Revenue
Description: GLAD Gladstone Capital December 26, 2025
Gladstone Capital Corporation (NASDAQ:GLAD) is a Business Development Company (BDC) that focuses on providing growth-capital and credit solutions to lower-middle-market U.S. companies, typically with $20 M–$150 M in revenue and $3 M–$25 M EBITDA.
The firm deploys a broad suite of financing structures-including senior term loans, unitranche, mezzanine, and equity-linked instruments-ranging from $8 M to $40 M per transaction, and it often takes minority equity positions to support add-on acquisitions and “buy-and-build” strategies.
Gladstone’s target industries are sector-agnostic but concentrate on business services, light and specialty manufacturing, niche industrial products, specialty consumer goods, energy services, transportation & logistics, healthcare & education, specialty chemicals, media & communications, and aerospace & defense.
From a market perspective, GLAD’s dividend yield (≈ 7.5% as of Q3 2025) and its net asset value (≈ $1.1 B) make it a relatively high-yielding BDC, while the firm’s performance is sensitive to credit-spread dynamics and the overall health of the U.S. lower-middle-market M&A environment.
Key economic drivers include the Federal Reserve’s policy stance-higher rates can compress loan pricing but also increase demand for refinancing-and the ongoing consolidation trend in fragmented industrial and service sectors, which fuels “buy-and-build” opportunities.
For a deeper quantitative view, you may want to explore GLAD’s metrics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 36.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.08 > 0.02 and ΔFCF/TA -14.30 > 1.0 |
| NWC/Revenue: -270.5% < 20% (prev 3.55%; Δ -274.0% < -1%) |
| CFO/TA -0.08 > 3% & CFO -71.5m > Net Income 36.9m |
| Net Debt (189.8m) to EBITDA (31.0m): 6.13 < 3 |
| Current Ratio: 0.05 > 1.5 & < 3 |
| Outstanding Shares: last quarter (28.4m) vs 12m ago 27.13% < -2% |
| Gross Margin: 77.45% > 18% (prev 0.83%; Δ 7662 % > 0.5%) |
| Asset Turnover: 7.78% > 50% (prev 15.55%; Δ -7.77% > 0%) |
| Interest Coverage Ratio: 1.46 > 6 (EBITDA TTM 31.0m / Interest Expense TTM 21.2m) |
Altman Z'' -1.04
| A: -0.20 (Total Current Assets 9.88m - Total Current Liabilities 192.7m) / Total Assets 922.8m |
| B: 0.01 (Retained Earnings 5.20m / Total Assets 922.8m) |
| C: 0.04 (EBIT TTM 31.0m / Avg Total Assets 869.2m) |
| D: 0.00 (Book Value of Equity 45.0k / Total Liabilities 416.3m) |
| Altman-Z'' Score: -1.04 = CCC |
What is the price of GLAD shares?
Over the past week, the price has changed by -2.59%, over one month by -10.02%, over three months by -0.87% and over the past year by -27.61%.
Is GLAD a buy, sell or hold?
- StrongBuy: 1
- Buy: 0
- Hold: 5
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the GLAD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 21.5 | 14.5% |
| Analysts Target Price | 21.5 | 14.5% |
| ValueRay Target Price | 21.7 | 15.4% |
GLAD Fundamental Data Overview February 13, 2026
P/E Forward = 11.5607
P/S = 4.6407
P/B = 0.8974
P/EG = 2.3116
Revenue TTM = 67.6m USD
EBIT TTM = 31.0m USD
EBITDA TTM = 31.0m USD
Long Term Debt = unknown (0.0)
Short Term Debt = 192.7m USD (from shortTermDebt, last quarter)
Debt = 192.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 189.8m USD (from netDebt column, last quarter)
Enterprise Value = 615.2m USD (425.4m + Debt 192.7m - CCE 2.92m)
Interest Coverage Ratio = 1.46 (Ebit TTM 31.0m / Interest Expense TTM 21.2m)
EV/FCF = -8.60x (Enterprise Value 615.2m / FCF TTM -71.5m)
FCF Yield = -11.63% (FCF TTM -71.5m / Enterprise Value 615.2m)
FCF Margin = -105.8% (FCF TTM -71.5m / Revenue TTM 67.6m)
Net Margin = 54.57% (Net Income TTM 36.9m / Revenue TTM 67.6m)
Gross Margin = 77.45% ((Revenue TTM 67.6m - Cost of Revenue TTM 15.2m) / Revenue TTM)
Gross Margin QoQ = none% (prev 71.74%)
Tobins Q-Ratio = 0.67 (Enterprise Value 615.2m / Total Assets 922.8m)
Interest Expense / Debt = 3.08% (Interest Expense 5.93m / Debt 192.7m)
Taxrate = 21.0% (US default 21%)
NOPAT = 24.5m (EBIT 31.0m * (1 - 21.00%))
Current Ratio = 0.05 (Total Current Assets 9.88m / Total Current Liabilities 192.7m)
Debt / Equity = 0.38 (Debt 192.7m / totalStockholderEquity, last quarter 506.5m)
Debt / EBITDA = 6.13 (Net Debt 189.8m / EBITDA 31.0m)
Debt / FCF = -2.65 (negative FCF - burning cash) (Net Debt 189.8m / FCF TTM -71.5m)
Total Stockholder Equity = 491.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.24% (Net Income 36.9m / Total Assets 922.8m)
RoE = 7.50% (Net Income TTM 36.9m / Total Stockholder Equity 491.8m)
RoCE = 6.30% (EBIT 31.0m / Capital Employed (Equity 491.8m + L.T.Debt 0.0))
RoIC = 2.99% (NOPAT 24.5m / Invested Capital 819.4m)
WACC = 6.72% (E(425.4m)/V(618.1m) * Re(8.66%) + D(192.7m)/V(618.1m) * Rd(3.08%) * (1-Tc(0.21)))
Discount Rate = 8.66% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 14.19%
Fair Price DCF = unknown (Cash Flow -71.5m)
EPS Correlation: 88.99 | EPS CAGR: 20.30% | SUE: 0.54 | # QB: 0
Revenue Correlation: 46.46 | Revenue CAGR: 15.90% | SUE: -0.14 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.48 | Chg30d=+0.005 | Revisions Net=+0 | Analysts=6
EPS current Year (2026-09-30): EPS=1.94 | Chg30d=+0.030 | Revisions Net=+0 | Growth EPS=-3.8% | Growth Revenue=+13.3%
EPS next Year (2027-09-30): EPS=1.92 | Chg30d=+0.052 | Revisions Net=+2 | Growth EPS=-1.1% | Growth Revenue=+6.2%